4//SEC Filing
Mattila Jyrki 4
Accession 0001123292-17-001368
CIK 0001588972other
Filed
Aug 20, 8:00 PM ET
Accepted
Aug 21, 5:56 PM ET
Size
7.9 KB
Accession
0001123292-17-001368
Insider Transaction Report
Form 4
Mattila Jyrki
Executive VP, Business Dev.
Transactions
- Award
Restricted Stock Units
2017-08-21+12,000→ 12,000 total→ Common Stock (12,000 underlying) - Award
Employee Stock Option (right to buy)
2017-08-21+75,000→ 75,000 totalExercise: $6.98Exp: 2027-08-21→ Common Stock (75,000 underlying)
Footnotes (3)
- [F1]The stock option vests in equal monthly installments over 48 months, beginning on the date that is one month from the date of grant, subject to continued employment with the Company. The stock option is an inducement grant under NASDAQ listing rule 5635(c)(4).
- [F2]Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.
- [F3]The restricted stock units vest in four equal annual installments beginning August 21, 2018. Vested shares will be delivered to the reporting person within 30 days following each respective vesting date. The restricted stock unit award is an inducement grant under NASDAQ listing rule 5635(c)(4).
Documents
Issuer
Recro Pharma, Inc.
CIK 0001588972
Entity typeother
Related Parties
1- filerCIK 0001297318
Filing Metadata
- Form type
- 4
- Filed
- Aug 20, 8:00 PM ET
- Accepted
- Aug 21, 5:56 PM ET
- Size
- 7.9 KB